PNC Financial Services Group
XERS icon

PNC Financial Services Group’s Xeris Biopharma Holdings XERS Stock Holding History

PNC Financial Services Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.67K Buy
1,221
+168
+16% +$1.07K ﹤0.01% 4106
2026
Q1 		$6.11K Buy
1,053
+654
+164% +$4.34K ﹤0.01% 4172
2025
Q4 		$3.13K Sell
399
-222
-36% -$1.75K ﹤0.01% 4407
2025
Q3 		$5.05K Buy
621
+27
+5% +$179 ﹤0.01% 4201
2025
Q2 		$2.77K Buy
594
+492
+482% +$2.25K ﹤0.01% 4313
2025
Q1 		$560 Buy
+102
New +$412 ﹤0.01% 4618
2024
Q1 		– Sell
-30
Closed -$71 – 4832
2023
Q4 		$71 Buy
+30
New +$55 ﹤0.01% 4538

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PNC Financial Services Group's XERS Position: Q2 2026 in Review

PNC Financial Services Group increased its Xeris Biopharma Holdings (XERS) stake by 16% in Q2 2026, buying an estimated $1.07K and bringing the position to 1,221 shares worth $9.67K. The position accounts for ﹤0.01% of the portfolio, ranked #4106.

PNC Financial Services Group first reported a position in XERS in Q4 2023 and has held it in 7 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • PNC Financial Services Group held 1,221 shares of Xeris Biopharma Holdings worth $9.67K as of Q2 2026.
  • PNC Financial Services Group bought 168 Xeris Biopharma Holdings shares in Q2 2026, an estimated $1.07K.
  • Xeris Biopharma Holdings made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4106 holding.
  • PNC Financial Services Group first reported a position in Xeris Biopharma Holdings in Q4 2023 and has held it in 7 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.